Chahat

Employment

• Hemwati Nandan Bahuguna Garhwal University PhD Scholar (JRF)
  2024 - Present
• Hemwati Nandan Bahuguna Garhwal University JRF
  2023 - 2025

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (15)

• COX-2 inhibitors in inflammation and cancer: Recent developments in medicinal chemistry
  Chahat, Shankar Gupta, Gaurav Joshi +2 more
  European Journal of Medicinal Chemistry 2026 DOI: 10.1016/j.ejmech.2026.118781
  +Save
• “Acne vulgaris: key insights, treatment, and future prospects”
  Molecular Diversity 2026 DOI: 10.1007/s11030-025-11209-3
  +Save
• A Comprehensive Review on Key Chemical Constituents of Indian Pulses and Their Multifaceted Health Benefits in a Global Context
  Preeti Semwal, Shankar Gupta, Chahat +3 more
  Legume Science 2025 DOI: 10.1002/leg3.70055
  +Save
• Reconnecting the roots of hydrogen sulfide (H2S) with medicinal chemistry: Lessons accomplished and challenges so far
  Chahat, Bhupinder Kumar, Shankar Gupta +2 more
  Bioorganic Chemistry 2025 DOI: 10.1016/j.bioorg.2025.108569
  +Save
• Advancements in targeting tumor suppressor genes (p53 and BRCA 1/2) in breast cancer therapy
  Chahat, Nidhi Nainwal, Yogesh Murti +4 more
  Molecular Diversity 2025 DOI: 10.1007/s11030-024-10964-z
  +Save
• Role of novel drug delivery systems in managing Alzheimer's disease
  Chahat, Abhimannu Shome, Pooja A. Chawla
  Novel Drug Delivery Systems in the management of CNS Disorders 2025 DOI: 10.1016/b978-0-443-13474-6.00031-7
  +Save
• Neuroprotective Effect of Natural Indole and β-carboline Alkaloids against Parkinson’s Disease: An Overview
  Abhimannu Shome, Chahat, Viney Chawla +1 more
  Current Medicinal Chemistry 2024 DOI: 10.2174/0929867331666230913100624
  +Save
• Alkaloids as Additional Weapons in the Fight against Breast Cancer: A Review
  Chahat, Keshav Taruneshwar Jha, Rohit Bhatia +1 more
  Current Medicinal Chemistry 2024 DOI: 10.2174/0929867331666230911162527
  +Save
• Cyclin-dependent kinase 4 and 6 in cancer: Exploration of CDK4/6 inhibitors as anticancer agents
  Nilay Kumar Nandi, Chahat, Rohit Bhatia +3 more
  Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy 2024 DOI: 10.1016/b978-0-323-96121-9.00006-1
  +Save
• EXPLORING THE BINDING MODES OF PIPERAZINE COMPOUNDS ON MAO-A FOR A STEP TOWARDS DEPRESSION THERAPY
  Keshav Taruneshwar Jha, Abhimannu Shome, Pooja A. Chawla
  INDIAN DRUGS 2023 DOI: 10.53879/id.60.12.14314
  +Save
• Nanometals: As click catalysts for 1,4-triazole cycloaddition (2020-till date)
  Keshav Taruneshwar Jha, Chahat, Pooja A. Chawla
  Sustainable Chemistry and Pharmacy 2023 DOI: 10.1016/j.scp.2023.101195
  +Save
• Medicinal perspectives and structure-activity relationship studies of pyrimidine based Bruton’s tyrosine kinase inhibitors as potential anticancer agents
  Keshav Taruneshwar Jha, Abhimannu Shome, Chahat +2 more
  Process Biochemistry 2023 DOI: 10.1016/j.procbio.2023.07.018
  +Save
• Recent advances in nitrogen-containing heterocyclic compounds as receptor tyrosine kinase inhibitors for the treatment of cancer: Biological activity and structural activity relationship
  Keshav Taruneshwar Jha, Abhimannu Shome, Chahat +1 more
  Bioorganic Chemistry 2023 DOI: 10.1016/j.bioorg.2023.106680
  +Save
• p53 as a potential target for treatment of cancer: A perspective on recent advancements in small molecules with structural insights and SAR studies
  Chahat, Rohit Bhatia, Bhupinder Kumar
  European Journal of Medicinal Chemistry 2023 DOI: 10.1016/j.ejmech.2022.115020
  +Save
• 10 Recent advancement in binding free-energy calculation
  +Save